Back to Search
Start Over
Predicting pathogens causing ventilator-associated pneumonia using a Bayesian network model
- Source :
- Journal of Antimicrobial Chemotherapy, 62, 184-188, Journal of Antimicrobial Chemotherapy, 62, 1, pp. 184-188
- Publication Year :
- 2008
-
Abstract
- Background: We previously validated a Bayesian network (BN) model for diagnosing ventilatorassociated pneumonia (VAP). Here, we report on the performance of the model to predict microbial causes of VAP and to select antibiotics. Methods: Pathogens were grouped into seven categories based upon the antibiotic susceptibility and epidemiological characteristics. Colonization of the upper respiratory tract was modelled in the BN and depended—in additional steps—on (i) duration of admission and ventilation, (ii) previous culture results and (iii) previous antibiotic use. A database with 153 VAP episodes and their microbial causes was used as reference standard. Appropriateness of antibiotic prescription, with fixed choices for pathogens predicted, was determined. Results: One hundred and seven VAP episodes were monobacterial and 46 were caused by two pathogens. Using duration of admission and ventilation only, areas under the receiver operating curve (AUC) ranged from 0.511 to 0.772 for different pathogen groups, and model predictions significantly improved when adding information on culture results, but not when adding information on antibiotic use. The best performing model (with all information) had AUC values ranging from 0.859 for Acinetobacter spp. to 0.929 for Streptococcus pneumoniae. With this model, 91 (85%) and 29 (63%) of all pathogen groups were correctly predicted for monobacterial and polymicrobial VAP, respectively. With fixed antibiotic choices linked to pathogen groups, 92% of all episodes would have been treated appropriately. Conclusions: The BN models’ performance to predict pathogens causing VAP improved markedly with information on colonization, resulting in excellent pathogen prediction and antibiotic selection. Prospective external validation is needed.
- Subjects :
- Microbiology (medical)
Artificial ventilation
medicine.medical_specialty
Time Factors
medicine.drug_class
medicine.medical_treatment
Antibiotics
medicine.disease_cause
law.invention
law
Internal medicine
Streptococcus pneumoniae
Software Science
medicine
Humans
Pharmacology (medical)
Intensive care medicine
Antibacterial agent
Pharmacology
Cross Infection
biology
business.industry
Ventilator-associated pneumonia
Pneumonia, Ventilator-Associated
Bayes Theorem
Bacterial Infections
Acinetobacter
medicine.disease
biology.organism_classification
Intensive care unit
Anti-Bacterial Agents
Pneumonia
Infectious Diseases
business
Subjects
Details
- ISSN :
- 03057453
- Database :
- OpenAIRE
- Journal :
- Journal of Antimicrobial Chemotherapy, 62, 184-188, Journal of Antimicrobial Chemotherapy, 62, 1, pp. 184-188
- Accession number :
- edsair.doi.dedup.....49b71301df6ea66b91ba30655bac0900
- Full Text :
- https://doi.org/10.1093/jac/dkn141